Read the case and answer the following questions:
-Considering both economic and ethical aspects, is it appropriate for companies such as Novo Nordisk to conduct clinical trials in, for example, India? What exactly are the principles that should guide such a decision?
– If trials are conducted in an emerging economy, how should they be managed and which standards should apply?
– How should Anders Dejgaard react when a journalist calls to discuss Novo Nordisk’s practices?